Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study
接受纳武利尤单抗联合伊匹木单抗治疗的活动性黑色素瘤脑转移患者的长期疗效（CheckMate 204）：一项开放标签、多中心、II期研究的最终结果
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(21)00545-3
Tawbi, Hussein A; Forsyth, Peter A; Hodi, F Stephen; Algazi, Alain P; Hamid, Omid; Lao, Christopher D; Moschos, Stergios J; Atkins, Michael B; Lewis, Karl; Postow, Michael A; Thomas, Reena P; Glaspy, John; Jang, Sekwon; Khushalani, Nikhil I; Pavlick, Anna C; Ernstoff, Marc S; Reardon, David A; Kudchadkar, Ragini; Tarhini, Ahmad; Chung, Caroline; Ritchings, Corey; Durani, Piyush; Askelson, Margarita; Puzanov, Igor; Margolin, Kim A
